Vasopressin-related copeptin is a novel predictor of early endothelial dysfunction in patients with adult polycystic kidney disease

Creative Commons License

KOÇYİĞİT I. , YILMAZ M. I. , Gungor O., EROĞLU E. , ÜNAL A. , Orscelik O., ...Daha Fazla

BMC NEPHROLOGY, cilt.17, 2016 (SCI İndekslerine Giren Dergi) identifier


Background: In this study, we examined the relative usefulness of serum copeptin levels as a surrogate marker of vasopressin (AVP) in adult polycystic kidney disease (ADPKD) by correlating it with baseline and longitudinal changes in markers of both renal function and common CVD manifestations (hypertensive vascular disease, atherosclerosis and endothelial dysfunction) that accompany the progression of this disease.